Well-Differentiated Liposarcoma (Atypical Lipomatous Tumour)

What Is a Well-Differentiated Liposarcoma?

A well-differentiated liposarcoma (often shortened to WDLPS) is a cancer that arises from fat cells — but it is by far the mildest and most common of the liposarcoma family. "Well-differentiated" is a pathology term that simply means the tumour cells still look a lot like the normal fat they came from. The more a tumour resembles its parent tissue, the lower its grade, and the more slowly and predictably it behaves. So the very phrase in your report that sounds frightening — liposarcoma — is paired with the most reassuring word a sarcoma report can carry.

It is the most frequent subtype of liposarcoma overall, and it sits at the gentle end of the spectrum that runs through myxoid, pleomorphic, and dedifferentiated liposarcoma. Compared with those higher-grade cousins, a well-differentiated liposarcoma grows slowly over months to years, rarely causes pain in its early stages, and — crucially — almost never spreads to the lungs or other organs while it stays purely well-differentiated. Its danger lies not in metastasis but in two local behaviours: it can come back where it was removed (local recurrence), and, in a small minority, a part of it can change into a higher-grade tumour over time (dedifferentiation).

If you would like the wider picture of how grade shapes the outlook for any sarcoma — not just this one — our companion guide on the sarcoma grade explained is a useful next read, and the full topic map sits on our sarcoma — overview hub.

Why Two Names? "Atypical Lipomatous Tumour" vs "Well-Differentiated Liposarcoma"

One of the most confusing things about this diagnosis is that two different names — atypical lipomatous tumour (ALT) and well-differentiated liposarcoma — describe what is microscopically the same tumour. The difference is not in the cells under the microscope; it is in where the tumour grows, because location decides what it can and cannot do.

In short: same biology, different stakes. An ALT in the thigh and a well-differentiated liposarcoma in the abdomen are made of the same kind of cells, but one is usually a one-operation cure and the other needs lifelong follow-up. This is why your report should state both the subtype and the exact location, and why a specialist reads them together rather than reacting to the word "liposarcoma" alone.

Is It Cancer, or Just a Big Lipoma? How WDLPS Differs From a Lipoma

A simple lipoma is a completely benign lump of fat — one of the most common growths in the body. A well-differentiated liposarcoma can look almost identical to a lipoma on the surface, and even under the microscope the two can be hard to tell apart. This overlap is exactly why a "fatty lump" should never be dismissed on appearance alone. Several clues raise the suspicion that a fatty mass is a WDLPS rather than a harmless lipoma:

• Size: most lipomas stay under 5 cm; a fatty mass larger than this, especially one that is still growing, needs imaging
• Depth: a lump that sits deep — beneath the muscle layer rather than just under the skin — is more concerning
• Growth: a fatty lump that is steadily enlarging, rather than staying the same size for years, is a red flag
• MRI features: thick fibrous bands ("septa"), areas that are not pure fat, and enhancement point towards a WDLPS

The single test that settles the question is MDM2 testing. A true lipoma does not amplify the MDM2 gene; a well-differentiated liposarcoma almost always does. This is covered in detail further down the page — but the take-home for now is that the safest way to be sure a fatty lump is "just a lipoma" is for a sarcoma centre to confirm it, not to assume it. If your lump has these features, our guidance on sarcoma treatment in Hyderabad explains the right pathway from imaging to diagnosis.

How Well-Differentiated Liposarcoma Is Diagnosed

Because a WDLPS can mimic a benign lipoma, the diagnosis rests on putting three pieces of evidence together — imaging, tissue, and genetics. At CION every fatty mass with suspicious features is worked up through the same disciplined pathway, so the answer is reliable the first time.

Step 1 — MRI Distinguishes Fat From Cancer

MRI is the imaging test of choice. A pure lipoma shows up as uniform fat. A well-differentiated liposarcoma typically shows thick or irregular fibrous septa, nodular areas that are not pure fat, and patchy enhancement after contrast. MRI also maps the tumour's exact size, depth, and its relationship to nearby muscles, vessels, and nerves — the information the surgeon needs to plan a clean removal.

Step 2 — Core Needle Biopsy

A core needle biopsy takes a thin cylinder of tissue under image guidance so the pathologist can examine the actual cells. The biopsy track is planned in coordination with the operating surgeon so it can later be removed within the surgical margin. A biopsy is preferred over removing the whole lump blindly, because an unplanned excision of a tumour that turns out to be a sarcoma can contaminate clean tissue and force a much larger second operation.

Step 3 — MDM2 / CDK4 Testing

This is the test that definitively separates a well-differentiated liposarcoma from a benign lipoma. WDLPS is driven by amplification of a region of chromosome 12 that contains the MDM2 and CDK4 genes. Pathologists confirm this either by FISH (a genetic test that counts extra copies of MDM2) or by immunohistochemistry staining. A lipoma does not show MDM2 amplification; a WDLPS does. When a fatty lump is borderline on the microscope, MDM2 testing is what gives a confident, final diagnosis — and it is exactly the kind of detail a non-specialist lab may not run, which is why a second-opinion pathology review at a sarcoma centre matters.

How Well-Differentiated Liposarcoma Is Treated

Treatment is decided by where the tumour is and how confidently it can be removed. Because WDLPS is low grade, chemotherapy plays no role in pure well-differentiated disease — it does not respond to it. The real decisions are surgical:

The thread running through all three is margin quality. Because WDLPS rarely spreads, its whole story is local control — and that is decided by how completely it is removed. This is why even a "low-grade" liposarcoma should be operated on by a sarcoma surgeon rather than treated as a routine lump removal, and why follow-up imaging continues for years to catch any local recurrence early.

Recurrence, Dedifferentiation, and the Outlook

The outlook for well-differentiated liposarcoma is, for most patients, excellent — but the prognosis is genuinely shaped by location, and it is worth being clear about both halves of the story.

For an atypical lipomatous tumour of a limb, complete removal is usually a cure. The risk of spread to distant organs is negligible, and provided the margin was clear, the chance of it returning is low. Patients are followed with periodic clinical checks and imaging, but the great majority go on to lead a normal life.

For a retroperitoneal well-differentiated liposarcoma, the situation requires more vigilance. Because the abdomen offers no clean planes to cut along and the tumour can be huge, complete removal is harder, and the tumour can recur locally over a span of years. The single most important long-term risk is dedifferentiation — a process in which an area within the tumour transforms into a higher-grade, more aggressive type (dedifferentiated liposarcoma) that can spread. This is uncommon, but it is the reason lifelong surveillance matters: catching a recurrence or a dedifferentiated focus early gives the best chance of controlling it.

Indicative Cost in Hyderabad

Costs are indicative. A personalised estimate is provided after your CION consultation. EMI options and cashless support through major TPAs, Aarogyasri, CGHS, ECHS & ESI are available for eligible patients.

Why Patients Choose CION for Liposarcoma Care

A well-differentiated liposarcoma is highly curable — but only when it is diagnosed precisely and removed properly the first time. Here is why patients trust CION.

Get Certainty About Your Diagnosis

A well-differentiated liposarcoma is one of the most treatable sarcomas — when it is correctly identified and completely removed. If you are holding a "fatty tumour" report or deciding on surgery, talk to a sarcoma specialist first.